NYSEAMERICAN:CTEK - CynergisTek Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.98 +0.03 (+0.76 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$3.98
Today's Range$3.8750 - $3.98
52-Week Range$2.70 - $5.45
Volume7,052 shs
Average Volume25,969 shs
Market Capitalization$47.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.86
CynergisTek logoCynergistek, Inc. provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients. The company also provides technical risk and penetration testing, process and procedure development, and risk management services based on its proprietary Delphiis IT Risk Manager SaaS Solution. It also serves financial institutions, and gaming and other industries. The company was formerly known as Auxilio, Inc. and changed its name to Cynergistek, Inc. in September 2017. Cynergistek, Inc. is based in Mission Viejo, California.

Receive CTEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CTEK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diversified Machinery
Sub-IndustryN/A
SectorIndustrial Products
SymbolNYSEAMERICAN:CTEK
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares9,620,000

The Truth About Cryptocurrencies

CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions

What is CynergisTek's stock symbol?

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

How were CynergisTek's earnings last quarter?

CynergisTek Inc (NYSEAMERICAN:CTEK) announced its quarterly earnings data on Monday, May, 14th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.10 by $0.05. The business had revenue of $16.38 million for the quarter, compared to analyst estimates of $17.45 million. View CynergisTek's Earnings History.

When is CynergisTek's next earnings date?

CynergisTek is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for CynergisTek.

What price target have analysts set for CTEK?

2 analysts have issued 1-year price targets for CynergisTek's stock. Their forecasts range from $7.20 to $8.25. On average, they expect CynergisTek's stock price to reach $7.7250 in the next year. View Analyst Ratings for CynergisTek.

Who are some of CynergisTek's key competitors?

Who are CynergisTek's key executives?

CynergisTek's management team includes the folowing people:
  • Mr. Paul T. Anthony, CFO, Corp. Sec. & Treasurer (Age 47)
  • Mr. Sean T. Hughes, Exec. VP of Managed Print Services
  • Mr. Michael H. McMillan, CEO, Pres, Chief Strategy Officer & Director (Age 61)
  • Dr. Michael G. Mathews, Chief Operating Officer and Director (Age 49)
  • Mr. Adam Hawkins, Sr. VP of Sales & Marketing

Has CynergisTek been receiving favorable news coverage?

Media headlines about CTEK stock have trended somewhat positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CynergisTek earned a news sentiment score of 0.14 on Accern's scale. They also assigned news articles about the company an impact score of 45.89 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are CynergisTek's major shareholders?

CynergisTek's stock is owned by many different of institutional and retail investors. Top institutional investors include ARS Investment Partners LLC (2.62%), King Luther Capital Management Corp (0.93%) and NJ State Employees Deferred Compensation Plan (0.56%). View Institutional Ownership Trends for CynergisTek.

Which institutional investors are selling CynergisTek stock?

CTEK stock was sold by a variety of institutional investors in the last quarter, including NJ State Employees Deferred Compensation Plan. View Insider Buying and Selling for CynergisTek.

Which institutional investors are buying CynergisTek stock?

CTEK stock was purchased by a variety of institutional investors in the last quarter, including ARS Investment Partners LLC and King Luther Capital Management Corp. View Insider Buying and Selling for CynergisTek.

How do I buy shares of CynergisTek?

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CynergisTek's stock price today?

One share of CTEK stock can currently be purchased for approximately $3.98.

How big of a company is CynergisTek?

CynergisTek has a market capitalization of $47.51 million.


MarketBeat Community Rating for CynergisTek (CTEK)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about CynergisTek and other stocks. Vote "Outperform" if you believe CTEK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTEK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.